Identify the differences between white, brown, and clear bagging for specialty medications, and what’s best suited for your covered entity
Over the last decade, many new biosimilars and specialty drugs have come to market. This has made treatment options for complex medical conditions more accessible to patients. While the availability of these drugs has improved dramatically over time, how these drugs are purchased or acquired and administered has recently changed.
These changes are not necessarily focused on ease-of-access for the patient or the location where the treatments will be administered. Historically, most hospitals utilized the “buy-and-bill” method when accessing specialty drugs for their patients. That is, the pharmacy purchased the drug through usual means and billed the patient’s insurance. Today, many Pharmacy Benefit Managers
(PBMs) are requiring the use of certain delivery methods to access these drugs, resulting in various safety, compliance, and regulatory risks for covered entities.
The three common terms used to describe these specialty medication delivery methods are white bagging, brown bagging, and clear bagging. Fill out the form below to learn more about all three, as well as additional considerations for if your facility is not able to implement a specialty pharmacy and retain the 340B savings: